MedPath

NEO-LARYNGOBIS

NEO-LARYNGOBIS

Approved
DIN Number

00065927

Drug Class

Human

Market Date

Dec 31, 1950

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00065927
AIG Number0108681002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R02AA20 VARIOUS
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification52:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BISMUTH DIPROPYLACETATEActive
Strength: 135 MG
Monograph: BISMUTH DIPROPYLACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.